R&D Non-opioid painkillers: Another tool to fight the opioid epi... The opioid epidemic is still an ongoing problem and there is no single solution to bring it under control.
News Rethinking pharmaceutical pain management beyond opioids – t... On the latest instalment of the pharmaphorum podcast, editor in chief Jonah Comstock hosts Tony Mack, CEO at Virpax Pharmaceuticals, in the virtual studio.
Views & Analysis Fifteen uses for Botox you never knew doctors talked about Other possible benefits include pain and depression.
News FDA clears Viridian's Tepezza rival for thyroid eye disease Viridian has fired a shot across Amgen's bows with the FDA approval of Tepezza rival Lumvoa in thyroid eye disease, a $2bn market.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
